CoChat

Toll‐Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility

Open access
Sameer, Aga Syed, Nissar, Saniya · 2021 · BioMed Research International

The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.

Abstract

Toll‐like receptors (TLRs) are the important mediators of inflammatory pathways in the gut which play a major role in mediating the immune responses towards a wide variety of pathogen‐derived ligands and link adaptive immunity with the innate immunity. Numerous studies in different populations across the continents have reported on the significant roles of TLR gene polymorphisms in modulating the risk of colorectal cancer (CRC). CRC is one of the major malignancies affecting the worldwide population and is currently ranking the third most common cancer in the world. In this review, we have attempted to discuss the structure, functions, and signaling of TLRs in comprehensive detail together with the role played by various TLR gene SNPs in CRC susceptibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2021/1157023

Cites

128 of 128 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A comparative structure of TLR and IL-R.
Figure 1 A comparative structure of TLR and IL-R.CC BY · PubMed Central
Figure 2 Detection of PAMPs by various TLRs.
Figure 2 Detection of PAMPs by various TLRs.CC BY · PubMed Central
Figure 3 Dynamics of the toll-like receptor signaling.
Figure 3 Dynamics of the toll-like receptor signaling.CC BY · PubMed Central
Figure 4 The two faces of the TLR signaling in carcinogenesis.
Figure 4 The two faces of the TLR signaling in carcinogenesis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 128 references

Research works printed but not linked: 1

  1. Ferlay J. Ervik M. Lam F. Cancer today (powered by GLOBOCAN 2018) IARC Cancer Base number 2018 p. 15 June 2021, https://publications.iarc.fr/Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018

Cited by

Items 201–300 of 322

Metadata

Authors
Sameer, A. S., & Nissar, S.
Affiliations
Government Medical College (IN)
Venue
BioMed Research International
Publisher
Wiley
Published
2021-01
Volume
2021
Issue
1
Pages
1157023-1157023
ISSN
  • 1110-7243 (ISSN-L)
  • 2314-6133
  • 2314-6141
OpenAlex
W3200104592
Cited by
323
References
128
Citations by year
2026: 41 · 2025: 90 · 2024: 101 · 2023: 62 · 2022: 29
FWCI
4.93
Type
journal article
Language
en
Open access
Locations
  • BioMed Research International (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
Toll-like receptors, colorectal cancer, genetic polymorphism, single nucleotide polymorphisms, Toll-like receptor signaling, innate immunity, intestinal inflammation, cancer susceptibility
MeSH terms
Humans, Ligands, Polymorphism, Genetic, Colorectal Neoplasms, Signal Transduction, Genetic Predisposition to Disease, Toll-Like Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.